New Zealand markets open in 2 hours

Genmab A/S (GMAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
38.21-0.43 (-1.11%)
As of 01:58PM EST. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 525.32B
Enterprise value 322.55B
Trailing P/E 58.97
Forward P/E 152.63
PEG ratio (5-yr expected) 15.82
Price/sales (ttm)21.41
Price/book (mrq)7.88
Enterprise value/revenue 32.85
Enterprise value/EBITDA 76.30

Trading information

Stock price history

Beta (5Y monthly) 0.61
52-week change 31.05%
S&P500 52-week change 327.11%
52-week high 349.07
52-week low 330.10
50-day moving average 343.46
200-day moving average 340.89

Share statistics

Avg vol (3-month) 3360.88k
Avg vol (10-day) 3437.92k
Shares outstanding 5654.04M
Implied shares outstanding 6N/A
Float 81.29B
% held by insiders 10.00%
% held by institutions 17.18%
Shares short (14 Nov 2021) 41.43M
Short ratio (14 Nov 2021) 44.19
Short % of float (14 Nov 2021) 4N/A
Short % of shares outstanding (14 Nov 2021) 40.22%
Shares short (prior month 14 Oct 2021) 41.25M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 25:1
Last split date 330 Apr 2018

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 36.34%
Operating margin (ttm)39.43%

Management effectiveness

Return on assets (ttm)8.56%
Return on equity (ttm)14.45%

Income statement

Revenue (ttm)7.91B
Revenue per share (ttm)12.09
Quarterly revenue growth (yoy)34.00%
Gross profit (ttm)10.11B
EBITDA 3.42B
Net income avi to common (ttm)2.87B
Diluted EPS (ttm)0.66
Quarterly earnings growth (yoy)67.90%

Balance sheet

Total cash (mrq)18.74B
Total cash per share (mrq)14.33
Total debt (mrq)437M
Total debt/equity (mrq)2.05
Current ratio (mrq)12.00
Book value per share (mrq)32.55

Cash flow statement

Operating cash flow (ttm)1.19B
Levered free cash flow (ttm)633.63M